These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3965587)

  • 1. Effects of exopolysaccharide production by viridans streptococci on penicillin therapy of experimental endocarditis.
    Pulliam L; Dall L; Inokuchi S; Wilson W; Hadley WK; Mills J
    J Infect Dis; 1985 Jan; 151(1):153-6. PubMed ID: 3965587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci.
    Dall L; Barnes WG; Lane JW; Mills J
    J Infect Dis; 1987 Nov; 156(5):736-40. PubMed ID: 3655403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT; Pelletier LL; Petersdorf RG
    J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
    Wilson WR; Zak O; Sande MA
    J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the vegetation in experimental Streptococcus viridans endocarditis.
    Hook EW; Sande MA
    Infect Immun; 1974 Dec; 10(6):1433-8. PubMed ID: 4497487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.
    Enzler MJ; Rouse MS; Henry NK; Geraci JE; Wilson WR
    J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exopolysaccharide production by viridans streptococci in experimental endocarditis.
    Mills J; Pulliam L; Dall L; Marzouk J; Wilson W; Costerton JW
    Infect Immun; 1984 Jan; 43(1):359-67. PubMed ID: 6690410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
    Henry NK; Wilson WR; Roberts RB; Acar JF; Geraci JE
    Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.
    Levy CS; Kogulan P; Gill VJ; Croxton MB; Kane JG; Lucey DR
    Clin Infect Dis; 2001 Aug; 33(4):577-9. PubMed ID: 11462199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the pre-treatment duration of infection on the efficacies of various antibiotic regimens in experimental streptococcal endocarditis.
    Crémieux AC; Saleh-Mghir A; Vallois JM; Muffat-Joly M; Devine C; Pocidalo JJ; Carbon C
    J Antimicrob Chemother; 1993 Dec; 32(6):843-52. PubMed ID: 8144424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F; Martín Luengo F; Valdés M
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with various antibiotics of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
    Martínez F; Martín-Luengo F; García A; Valdés M
    Eur Heart J; 1995 May; 16(5):687-91. PubMed ID: 7588902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
    Pelletier LL; Durack DT; Petersdorf RG
    J Clin Invest; 1975 Aug; 56(2):319-30. PubMed ID: 1150874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis.
    Brennan RO; Durack DT
    Antimicrob Agents Chemother; 1983 Feb; 23(2):273-7. PubMed ID: 6838188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of penicillin tolerance in vivo: prevention of experimental Streptococcus sanguis endocarditis.
    Hess J; Dankert J; Durack D
    J Antimicrob Chemother; 1983 Jun; 11(6):555-64. PubMed ID: 6885680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F; Martín-Luengo F; García A; Valdés M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.
    Brandt CM; Warner CB; Rouse MS; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clindamycin effect on glycocalyx production in experimental viridans streptococcal endocarditis.
    Dall L; Keilhofner M; Herndon B; Barnes W; Lane J
    J Infect Dis; 1990 Jun; 161(6):1221-4. PubMed ID: 2345303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis.
    Lowy FD; Neuhaus EG; Chang DS; Steigbigel NH
    Antimicrob Agents Chemother; 1983 Jan; 23(1):67-73. PubMed ID: 6830210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial endocarditis due to penicillin-resistant Streptococcus viridans.
    McCarthy VP; Cho CT; Diehl AM; Ramsey BW
    Clin Pediatr (Phila); 1979 May; 18(5):263-6. PubMed ID: 109241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.